Clinical Trial Update: AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update shows AMX0114 is recruiting in adults with amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• AMX0114

Snippet

Sponsor: Amylyx Pharmaceuticals Inc. | Conditions: ALS | Phase 1 | Status: RECRUITING